UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013696
Receipt number R000015935
Scientific Title Glaucoma Research on Adherence to Fixed Combination Eye Drops study
Date of disclosure of the study information 2014/04/11
Last modified on 2014/04/11 17:29:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Glaucoma Research on Adherence to Fixed Combination Eye Drops study

Acronym

GRACE study

Scientific Title

Glaucoma Research on Adherence to Fixed Combination Eye Drops study

Scientific Title:Acronym

GRACE study

Region

Japan


Condition

Condition

primary open angle glaucoma,pseudo-exfoliation glaucoma,ocular hypertension

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze factors affecting glaucoma treatment adherence in Japanese glaucoma patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Efficacy
To analyze factors affecting glaucoma treatment adherence

Key secondary outcomes



Base

Study type


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

give the patients adherence guidance for both tolerability and effect of glaucoma treatment after 1 month follow up

Interventions/Control_2

give the patients adherence guidance for only tolerability of glaucoma treatment after 1 month follow up

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients under treatment without glaucoma fixed combination eye drops.
2.Patients needed treatment of glaucoma fixed combination drugs.
3.Patients agreee with this study.

Key exclusion criteria

1.Changes of any glaucoma treatment under this study.
2.No recording at forgotten administration of glaucoma treatment in the questionaire.
3.Patients who are judged to be inappropriate for participation in the study for other reason by the doctor in charge.

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Makoto Araie

Organization

Kanto Central Hospital of The Mutual Aid Association of Public School

Division name

Director

Zip code


Address

6-25-1,Kamiyoga,Setagaya,Tokyo,Japan

TEL

03-3429-1171

Email

araie-tky@umin.net


Public contact

Name of contact person

1st name
Middle name
Last name Toyoaki Tsumura

Organization

Fussa Hospital

Division name

department of ophthalmology

Zip code


Address

1-6-1,Kamidaira,Fussa,Tokyo,Japan

TEL

042-551-1111

Homepage URL


Email

tsumura@fussahsp.jp


Sponsor or person

Institute

Glaucoma EyeDrops Adherence Council

Institute

Department

Personal name



Funding Source

Organization

Pfizer Japan Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

shinwa Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関東中央病院(東京都)山梨大学附属病院(山梨県)、東海大学八王子病院(東京都)、中野総合病院(東京都)、吉川眼科クリニック(東京都)、前田眼科クリニック(東京都)、公立福生病院(東京都)、その他1074施設


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 11 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications

http://pfizerpro.jp/cs/sv/grace/graceC_D/generalcontents/1259683469382/?f=rec2&aid=promo_contents

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2011 Year 04 Month 21 Day

Date of IRB


Anticipated trial start date

2011 Year 08 Month 04 Day

Last follow-up date

2012 Year 10 Month 30 Day

Date of closure to data entry

2012 Year 10 Month 30 Day

Date trial data considered complete

2014 Year 01 Month 19 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 11 Day

Last modified on

2014 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015935


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name